Precision oncology pioneer offering blood-based liquid biopsy tests for cancer therapy selection and early detection.
Werbung
Werbung
RGH
Rang #11253Guardant Health, Inc. rStock
175.42
+0.30515857392
+0.17%
24. Sept., 21:25 UTC
Über
Info & Links
Webseite
Verträge
- arbitrum-one:0xed2…534e9
- morph-l2:0xcdc…43c15
Weiterlesen
Daten von